Acanthamoeba keratitis: A rare infectious eye disease is targeted by a new drug treatment under development by a European consortium

ODAK is an industry led FP7 project which aims to develop a safe and effective treatment for a rare eye disease Acanthamoeba keratitis (AK), a devastating and severely debilitating condition which can lead to blindness and in over 85% of cases associated with contact lens wearing.AK is caused by a common protozoan (Acanthamoeba spp.

Full Story →